help button home button Am J Pathol ASIP MEMBERSHIP
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Originally published online as doi:10.2353/ajpath.2007.070342 on June 28, 2007

Published online before print June 28, 2007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ajpath.2007.070342v1
171/2/375    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pollack, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pollack, J. R.
(American Journal of Pathology. 2007;171:375-385.)
© 2007 American Society for Investigative Pathology
DOI: 10.2353/ajpath.2007.070342

Amgen Award Lecture

A Perspective on DNA Microarrays in Pathology Research and Practice

Jonathan R. Pollack

From the Department of Pathology, Stanford University, Stanford, California

Abstract

DNA microarray technology matured in the mid-1990s, and the past decade has witnessed a tremendous growth in its application. DNA microarrays have provided powerful tools for pathology researchers seeking to describe, classify, and understand human disease. There has also been great expectation that the technology would advance the practice of pathology. This review highlights some of the key contributions of DNA microarrays to experimental pathology, focusing in the area of cancer research. Also discussed are some of the current challenges in translating utility to clinical practice.




This article has been cited by other articles:


Home page
 Am. J. Pathol.Home page
P. B. Romesser, D. H. Perlman, D. V. Faller, C. E. Costello, M. E. McComb, and G. V. Denis
Development of a Malignancy-Associated Proteomic Signature for Diffuse Large B-Cell Lymphoma
Am. J. Pathol., July 1, 2009; 175(1): 25 - 35.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
A. de Reynies, G. Assie, D. S. Rickman, F. Tissier, L. Groussin, F. Rene-Corail, B. Dousset, X. Bertagna, E. Clauser, and J. Bertherat
Gene Expression Profiling Reveals a New Classification of Adrenocortical Tumors and Identifies Molecular Predictors of Malignancy and Survival
J. Clin. Oncol., March 1, 2009; 27(7): 1108 - 1115.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
B. J. Wouters, B. Lowenberg, and R. Delwel
A decade of genome-wide gene expression profiling in acute myeloid leukemia: flashback and prospects
Blood, January 8, 2009; 113(2): 291 - 298.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
E.-S. Lee, D.-S. Son, S.-H. Kim, J. Lee, J. Jo, J. Han, H. Kim, H. J. Lee, H. Y. Choi, Y. Jung, et al.
Prediction of Recurrence-Free Survival in Postoperative Non-Small Cell Lung Cancer Patients by Using an Integrated Model of Clinical Information and Gene Expression
Clin. Cancer Res., November 15, 2008; 14(22): 7397 - 7404.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the American Society for Investigative Pathology.